Phase I clinical trial of the bispecific antibody MDX-H210 (anti_FcgrammaRI x anti-HER-2/neu in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer.

R. Repp; H.H. van Ojik; T. Valerius; G. Groenewegen; G. Wieland; C. Oetzel; B. Stockmeyer; W.-D. Becker; M. Eisenhut; H. Steininger; Y.M. Deo; G.H. Blijham; J.R. Kalden; J.G.J. van de Winkel; M. Gramatzki

Phase I clinical trial of the bispecific antibody MDX-H210 (anti_FcgrammaRI x anti-HER-2/neu in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer.

Translated title of the contribution: Phase I clinical trial of the bispecific antibody MDX-H210 (anti_FcgrammaRI x anti-HER-2/neu in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer.

R. Repp
, H.H. van Ojik
, T. Valerius
, G. Groenewegen
, G. Wieland
, C. Oetzel
, B. Stockmeyer
, W.-D. Becker
, M. Eisenhut
, H. Steininger
, Y.M. Deo
, G.H. Blijham
, J.R. Kalden
, J.G.J. van de Winkel
, M. Gramatzki

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Phase I clinical trial of the bispecific antibody MDX-H210 (anti_FcgrammaRI x anti-HER-2/neu in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer.
Original language	Undefined/Unknown
Pages (from-to)	2234-43
Number of pages	10
Journal	British Journal of Cancer
Volume	15
Issue number	89
Publication status	Published - 2003

Keywords

Econometric and Statistical Methods: General
Geneeskunde (GENK)
Geneeskunde(GENK)
Algemeen onderzoek
Bescherming en bevordering van de menselijke gezondheid
Immunology
Internal medicine

Cite this

Repp, R., van Ojik, H. H., Valerius, T., Groenewegen, G., Wieland, G., Oetzel, C., Stockmeyer, B., Becker, W.-D., Eisenhut, M., Steininger, H., Deo, Y. M., Blijham, G. H., Kalden, J. R., van de Winkel, J. G. J., & Gramatzki, M. (2003). Phase I clinical trial of the bispecific antibody MDX-H210 (anti_FcgrammaRI x anti-HER-2/neu in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer. British Journal of Cancer, 15(89), 2234-43.

@article{74b4cbd85bad44259cc7229f53cf879b,

title = "Phase I clinical trial of the bispecific antibody MDX-H210 (anti\_FcgrammaRI x anti-HER-2/neu in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer.",

keywords = "Econometric and Statistical Methods: General, Geneeskunde (GENK), Geneeskunde(GENK), Algemeen onderzoek, Bescherming en bevordering van de menselijke gezondheid, Immunology, Internal medicine",

author = "R. Repp and \{van Ojik\}, H.H. and T. Valerius and G. Groenewegen and G. Wieland and C. Oetzel and B. Stockmeyer and W.-D. Becker and M. Eisenhut and H. Steininger and Y.M. Deo and G.H. Blijham and J.R. Kalden and \{van de Winkel\}, J.G.J. and M. Gramatzki",

year = "2003",

language = "Undefined/Unknown",

volume = "15",

pages = "2234--43",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Springer Nature",

number = "89",

}

Repp, R, van Ojik, HH, Valerius, T, Groenewegen, G, Wieland, G, Oetzel, C, Stockmeyer, B, Becker, W-D, Eisenhut, M, Steininger, H, Deo, YM, Blijham, GH, Kalden, JR, van de Winkel, JGJ & Gramatzki, M 2003, 'Phase I clinical trial of the bispecific antibody MDX-H210 (anti_FcgrammaRI x anti-HER-2/neu in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer.', British Journal of Cancer, vol. 15, no. 89, pp. 2234-43.

TY - JOUR

T1 - Phase I clinical trial of the bispecific antibody MDX-H210 (anti_FcgrammaRI x anti-HER-2/neu in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer.

AU - Repp, R.

AU - van Ojik, H.H.

AU - Valerius, T.

AU - Groenewegen, G.

AU - Wieland, G.

AU - Oetzel, C.

AU - Stockmeyer, B.

AU - Becker, W.-D.

AU - Eisenhut, M.

AU - Steininger, H.

AU - Deo, Y.M.

AU - Blijham, G.H.

AU - Kalden, J.R.

AU - van de Winkel, J.G.J.

AU - Gramatzki, M.

PY - 2003

Y1 - 2003

KW - Econometric and Statistical Methods: General

KW - Geneeskunde (GENK)

KW - Geneeskunde(GENK)

KW - Algemeen onderzoek

KW - Bescherming en bevordering van de menselijke gezondheid

KW - Immunology

KW - Internal medicine

M3 - Article

SN - 0007-0920

VL - 15

SP - 2234

EP - 2243

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 89

ER -